The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel
Abstract
CONTEXT: New trial data and drug regimens that have become available in the last 2 years warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected adults in resource-rich settings. OBJECTIVE: To provide current recommendations for the treatment of adult HIV infection with ART and use of laboratory-monitoring tools. Guidelines include when to start therapy and with what drugs, monitoring for response and toxic effects, special considerations in therapy, and managing antiretroviral failure. DATA SOURCES, STUDY SELECTION, AND DATA EXTRACTION: Data that had been published or presented in abstract form at scientific conferences in the past 2 years were systematically searched and reviewed by an International Antiviral Society-USA panel. The panel reviewed available evidence and formed recommendations by full panel consensus. DATA SYNTHESIS: Treatment is recommended for all adults with HIV infection; the strength of the recommendation and the quality of the evidence increase with decreasing CD4 cell count and the presence of certain concurrent conditions. Recommended initial regimens include 2 nucleoside reverse transcriptase inhibitors (tenofovir/emtricitabine or abacavir/lamivudine) plus a nonnucleoside reverse transcriptase inhibitor (efavirenz), a ritonavir-boosted protease inhibitor (atazanavir or darunavir), or an integrase strand transfer inhibitor (raltegravir). Alternatives in each class are recommended for patients with or at risk of certain concurrent conditions. CD4 cell count and HIV-1 RNA level should be monitored, as should engagement in care, ART adherence, HIV drug resistance, and quality-of-care indicators. Reasons for regimen switching include virologic, immunologic, or clinical failure and drug toxicity or intolerance. Confirmed treatment failure should be addressed promptly and multiple factors considered. CONCLUSION: New recommendations for HIV patient care include offering ART to all patients regardless of CD4 cell count, changes in therapeutic options, and modifications in the timing and choice of ART in the setting of opportunistic illnesses such as cryptococcal disease and tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
Sexually transmitted disease surveillance.
Schofield, C. B. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-c · Cited by 1,869
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., Monforte, A. D., de Wolf, F., Reiss, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09411-4 · Cited by 1,525
Self-citationClass of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Palella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,350
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Self-citationHIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Thio, C. L., Seaberg, E. C., Skolasky, R., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11913-1 · Cited by 1,099
Self-citationFixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis
Bangalore, S., Kamalakkannan, G., Parkar, S., & Messerli, F. H. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.033 · Cited by 1,075
Treatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M. A., Carpenter, C. C. J., Fischl, M. A., Gazzard, B. G., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,033
Self-citationAttia, S., Egger, M., Müller, M., Zwahlen, M., & Low, N. (2009) · AIDS · doi:10.1097/qad.0b013e32832b7dca · Cited by 1,001
Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., et al. (1998) · JAMA · doi:10.1001/jama.280.1.78 · Cited by 995
Self-citationPatel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Gallant, J. E., DeJesus, E., Arribas, J. R., Pozniak, A. L., Gazzard, B., Campo, R. E., Lu, B., McColl, D., Chuck, S., Enejosa, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051871 · Cited by 880
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P., Anderson, J. R., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 837
Self-citationThe Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Hirsch, M. S., Brun-Vézinet, F., D'Aquila, R. T., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Loveday, C., Mellors, J. W., Clotet, B., Conway, B., et al. (2000) · JAMA · doi:10.1001/jama.283.18.2417 · Cited by 766
Self-citation. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00003 · Cited by 748
Treatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel
Yeni, P. G., Hammer, S. M., Hirsch, M. S., Saag, M. S., Schechter, M., Carpenter, C. C. J., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Jacobsen, D. M., et al. (2004) · JAMA · doi:10.1001/jama.292.2.251 · Cited by 737
Self-citationRaltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
Steigbigel, R. T., Cooper, D. A., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Gatell, J. M., Rockstroh, J. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708975 · Cited by 691
Self-citationClass-Sparing Regimens for Initial Treatment of HIV-1 Infection
Riddler, S. A., Haubrich, R., DiRienzo, A. G., Peeples, L., Powderly, W. G., Klingman, K. L., Garren, K. W., George, T., Rooney, J. F., Brizz, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074609 · Cited by 680
Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676
HIV-1 Transmission, by Stage of Infection
Hollingsworth, T. D., Anderson, R. M., & Fraser, C. (2008) · The Journal of Infectious Diseases · doi:10.1086/590501 · Cited by 652
Worm, S. W., Sabin, C., Weber, R., Reiss, P., El‐Sadr, W., Dabis, F., De Wit, S., Law, M., Monforte, A. D., Friis‐Møller, N., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/649897 · Cited by 648
Self-citationLennox, J. L., DeJesus, E., Lazzarin, A., Pollard, R. B., Madruga, J. V. R., Berger, D. S., Zhao, J., Xu, X., Williams-Diaz, A., Rodgers, A. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60918-1 · Cited by 625
Gupta, S. K., Eustace, J. A., Winston, J. A., Boydstun, I. I., Ahuja, T. S., Rodriguez, R. A., Tashima, K. T., Roland, M., Franceschini, N., Palella, F. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/430257 · Cited by 581
Hirsch, M. S., Günthard, H. F., Schapiro, J. M., Brun‐Vézinet, F., Clotet, B., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Mellors, J. W., Pillay, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/589297 · Cited by 573
Self-citationZolopa, A. R., Andersen, J., Komarow, L., Sanne, I., Sanchez, A., Hogg, E., Suckow, C., Powderly, W., & for the ACTG A5164 study team (2009) · PLoS ONE · doi:10.1371/journal.pone.0005575 · Cited by 567
Montaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., & Harrigan, P. R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69162-9 · Cited by 555
Carpenter, C. C. J. (1996) · JAMA · doi:10.1001/jama.276.2.146 · Cited by 541
Antiretroviral Therapy for HIV Infection: A Knowledge-Based Approach to Drug Selection and Use
Moyle, G. J., Gazzard, B. G., Cooper, D. A., & Gatell, J. (1998) · Drugs · doi:10.2165/00003495-199855030-00005 · Cited by 536
Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K., & Spengler, U. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14844-1 · Cited by 525
Madruga, J. V., Cahn, P., Grinsztejn, B., Haubrich, R., Lalezari, J., Mills, A., Pialoux, G., Wilkin, T., Peeters, M., Vingerhoets, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61047-2 · Cited by 517
Self-citationThe Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
Freedberg, K. A., Losina, E., Weinstein, M. C., Paltiel, A. D., Cohen, C. J., Seage, G. R., Craven, D. E., Zhang, H., Kimmel, A. D., & Goldie, S. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441108 · Cited by 508
Bhaskaran, K. (2008) · JAMA · doi:10.1001/jama.300.1.51 · Cited by 496
Molina, J.-M., Andrade-Villanueva, J., Echevarria, J., Chetchotisakd, P., Corral, J., David, N., Moyle, G., Mancini, M., Percival, L., Yang, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61081-8 · Cited by 486
The Periodic Health Examination
(1934) · New England Journal of Medicine · doi:10.1056/nejm193401252100413 · Cited by 483
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients
De Wit, S., Sabin, C. A., Weber, R., Worm, S. W., Reiss, P., Cazanave, C., El-Sadr, W., Monforte, A. D., Fontas, E., Law, M. G., et al. (2008) · Diabetes Care · doi:10.2337/dc07-2013 · Cited by 482
Self-citationPalella, F. J., Deloria-Knoll, M., Chmiel, J. S., Moorman, A. C., Wood, K. C., Greenberg, A. E., Holmberg, S. D., & and the HIV Outpatient Study (HOPS) Investigators* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00007 · Cited by 443
Saag, M., Balu, R., Phillips, E., Brachman, P., Martorell, C., Burman, W., Stancil, B., Mosteller, M., Brothers, C., Wannamaker, P., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/529382 · Cited by 425
Moore, R. D., & Keruly, J. C. (2007) · Clinical Infectious Diseases · doi:10.1086/510746 · Cited by 415
Markowitz, M., Nguyen, B.-Y., Gotuzzo, E., Mendo, F., Ratanasuwan, W., Kovacs, C., Prada, G., Morales-Ramirez, J. O., Crumpacker, C. S., Isaacs, R. D., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318157131c · Cited by 408
Misovich, S. J., Fisher, J. D., & Fisher, W. A. (1997) · Review of General Psychology · doi:10.1037//1089-2680.1.1.72 · Cited by 405
Lewden, C., Chêne, G., Morlat, P., Raffi, F., Dupon, M., Dellamonica, P., Pellegrin, J.-L., Katlama, C., Dabis, F., & Leport, C. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318134257a · Cited by 402
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/586713 · Cited by 399
Ortiz, R., DeJesus, E., Khanlou, H., Voronin, E., van Lunzen, J., Andrade-Villanueva, J., Fourie, J., De Meyer, S., De Pauw, M., Lefebvre, E., et al. (2008) · AIDS · doi:10.1097/qad.0b013e32830285fb · Cited by 387
Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV
Castilla, J., del Romero, J., Hernando, V., Marincovich, B., García, S., & Rodríguez, C. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000157389.78374.45 · Cited by 384
Interleukin-2 Therapy in Patients with HIV Infection
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903175 · Cited by 381
Markowitz, M., Morales-Ramirez, J. O., Nguyen, B.-Y., Kovacs, C. M., Steigbigel, R. T., Cooper, D. A., Liporace, R., Schwartz, R., Isaacs, R., Gilde, L. R., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31802b4956 · Cited by 368
Nelson, M. R., Katlama, C., Montaner, J. S., Cooper, D. A., Gazzard, B., Clotet, B., Lazzarin, A., Schewe, K., Lange, J., Wyatt, C., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3280b07b33 · Cited by 352
Eron, J., Yeni, P., Gathe, J., Estrada, V., DeJesus, E., Staszewski, S., Lackey, P., Katlama, C., Young, B., Yau, L., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69155-1 · Cited by 344
Self-citationWood, E., Kerr, T., Marshall, B. D. L., Li, K., Zhang, R., Hogg, R. S., Harrigan, P. R., & Montaner, J. S. G. (2009) · BMJ · doi:10.1136/bmj.b1649 · Cited by 342
Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction
Triant, V. A., Meigs, J. B., & Grinspoon, S. K. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181a9992c · Cited by 338
Madruga, J. V., Berger, D., McMurchie, M., Suter, F., Banhegyi, D., Ruxrungtham, K., Norris, D., Lefebvre, E., de Béthune, M.-P., Tomaka, F., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61049-6 · Cited by 336
Nephropathy and Establishment of a Renal Reservoir of HIV Type 1 during Primary Infection
Winston, J. A., Bruggeman, L. A., Ross, M. D., Jacobson, J., Ross, L., D'Agati, V. D., Klotman, P. E., & Klotman, M. E. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442604 · Cited by 315
Tenofovir-Associated Acute and Chronic Kidney Disease: A Case of Multiple Drug Interactions
Zimmermann, A. E., Pizzoferrato, T., Bedford, J., Morris, A., Hoffman, R., & Braden, G. (2006) · Clinical Infectious Diseases · doi:10.1086/499048 · Cited by 314
Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
Sax, P. E., Tierney, C., Collier, A. C., Fischl, M. A., Mollan, K., Peeples, L., Godfrey, C., Jahed, N. C., Myers, L., Katzenstein, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906768 · Cited by 313
Crystalluria and Urinary Tract Abnormalities Associated with Indinavir
Kopp, J. B., Miller, K. D., Mican, J. A. M., Feuerstein, I. M., Vaughan, E., Baker, C., Pannell, L. K., & Falloon, J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-2-199707150-00004 · Cited by 312
Goicoechea, M., Liu, S., Best, B., Sun, S., Jain, S., Kemper, C., Witt, M., Diamond, C., Haubrich, R., Louie, S., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/524061 · Cited by 299
Law, M., Friis‐Møller, N., El‐Sadr, W., Weber, R., Reiss, P., D'Arminio Monforte, A., Thiébaut, R., Morfeldt, L., De Wit, S., Pradier, C., et al. (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00362.x · Cited by 298
Self-citationMartin, A., Smith, D. E., Carr, A., Ringland, C., Amin, J., Emery, S., Hoy, J., Workman, C., Doong, N., Freund, J., et al. (2004) · AIDS · doi:10.1097/00002030-200404300-00011 · Cited by 297
Self-citationRauch, A., Nolan, D., Martin, A., McKinnon, E., Almeida, C., & Mallal, S. (2006) · Clinical Infectious Diseases · doi:10.1086/504874 · Cited by 296
The HBV Drug Entecavir — Effects on HIV-1 Replication and Resistance
McMahon, M. A., Jilek, B. L., Brennan, T. P., Shen, L., Zhou, Y., Wind-Rotolo, M., Xing, S., Bhat, S., Hale, B., Hegarty, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067710 · Cited by 292
Lucas, G. M., Eustace, J. A., Sozio, S., Mentari, E. K., Appiah, K. A., & Moore, R. D. (2004) · AIDS · doi:10.1097/00002030-200402200-00022 · Cited by 268
Mills, A., Nelson, M. R., Jayaweera, D. T., Ruxrungtham, K., Cassetti, I., Girard, P., Workman, C., Dierynck, I., Sekar, V. J., Abeele, C. V., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832d7350 · Cited by 268
Haubrich, R. H., Riddler, S. A., DiRienzo, A. G., Komarow, L., Powderly, W. G., Klingman, K., Garren, K. W., Butcher, D. L., Rooney, J. F., Haas, D. W., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832b4377 · Cited by 254
Gupta, R. K., Hill, A., Sawyer, A. W., Cozzi-Lepri, A., von Wyl, V., Yerly, S., Lima, V. D., Günthard, H. F., Gilks, C., & Pillay, D. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70136-7 · Cited by 254
Self-citationBetter Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis
Parienti, J., Bangsberg, D. R., Verdon, R., & Gardner, E. M. (2009) · Clinical Infectious Diseases · doi:10.1086/596482 · Cited by 244
Predictors of proteinuria and renal failure among women with HIV infection
Szczech, L. A., Gange, S. J., van der Horst, C., Bartlett, J. A., Young, M., Cohen, M. H., Anastos, K., Klassen, P. S., & Svetkey, L. P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00094.x · Cited by 241
Phillips, A. N., Carr, A., Neuhaus, J., Visnegarwala, F., Prineas, R., Burman, W. J., Williams, I., Drummond, F., Duprez, D., Belloso, W. H., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300215 · Cited by 240
Yazdanpanah, Y., Fagard, C., Descamps, D., Taburet, A. M., Colin, C., Roquebert, B., Katlama, C., Pialoux, G., Jacomet, C., Piketty, C., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/630210 · Cited by 239
Arribas, J. R., Pozniak, A. L., Gallant, J. E., DeJesus, E., Gazzard, B., Campo, R. E., Chen, S.-S., McColl, D., Holmes, C. B., Enejosa, J., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815acab8 · Cited by 235
Harrison, K. M., Song, R., & Zhang, X. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b563e7 · Cited by 231
Pozniak, A. L., Gallant, J. E., DeJesus, E., Arribas, J. R., Gazzard, B., Campo, R. E., Chen, S.-S., McColl, D., Enejosa, J., Toole, J. J., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000245886.51262.67 · Cited by 231
Nikolopoulos, G. K., Paraskevis, D., Hatzitheodorou, E., Moschidis, Z., Sypsa, V., Zavitsanos, X., Kalapothaki, V., & Hatzakis, A. (2009) · Clinical Infectious Diseases · doi:10.1086/599110 · Cited by 231
L??pez-Cort??s, L. F., Ruiz-Valderas, R., Viciana, P., Alarc??n-Gonz??lez, A., G??mez-Mateos, J., Le??n-Jimenez, E., Sarasanacenta, M., L??pez-Pua, Y., & Pach??n, J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241090-00004 · Cited by 229
Gulick, R. M. (2006) · JAMA · doi:10.1001/jama.296.7.769 · Cited by 219
Kempf, D. J., King, M. S., Bernstein, B., Cernohous, P., Bauer, E., Moseley, J., Gu, K., Hsu, A., Brun, S., & Sun, E. (2004) · The Journal of Infectious Diseases · doi:10.1086/380509 · Cited by 217
Smith, K. Y., Patel, P., Fine, D., Bellos, N., Sloan, L., Lackey, P., Kumar, P. N., Sutherland-Phillips, D. H., Vavro, C., Yau, L., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832cbcc2 · Cited by 217
Antiretroviral drugs and liver injury
Soriano, V., Puoti, M., Garcia-Gascó, P., Rockstroh, J. K., Benhamou, Y., Barreiro, P., & McGovern, B. (2008) · AIDS · doi:10.1097/qad.0b013e3282f0e2fd · Cited by 216
Metzner, K. J., Giulieri, S. G., Knoepfel, S. A., Rauch, P., Burgisser, P., Yerly, S., Günthard, H. F., & Cavassini, M. (2009) · Clinical Infectious Diseases · doi:10.1086/595703 · Cited by 212
Self-citationLundgren, J., Battegay, M., Behrens, G., De Wit, S., Guaraldi, G., Katlama, C., Martinez, E., Nair, D., Powderly, W., Reiss, P., et al. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00534.x · Cited by 210
Self-citationLima, V. D., Johnston, K., Hogg, R. S., Levy, A. R., Harrigan, P. R., Anema, A., & Montaner, J. S. G. (2008) · The Journal of Infectious Diseases · doi:10.1086/588673 · Cited by 208
The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV-infected Patients
Kiser, J., Carten, M., Aquilante, C., Anderson, P., Wolfe, P., King, T., Delahunty, T., Bushman, L., & Fletcher, C. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100269 · Cited by 206
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/529523 · Cited by 204
Boulle, A. (2008) · JAMA · doi:10.1001/jama.300.5.530 · Cited by 201
Freedman, B. I., Hicks, P. J., Bostrom, M. A., Cunningham, M. E., Liu, Y., Divers, J., Kopp, J. B., Winkler, C. A., Nelson, G. W., Langefeld, C. D., et al. (2009) · Kidney International · doi:10.1038/ki.2008.701 · Cited by 189
Brothers, C. H., Hernandez, J. E., Cutrell, A. G., Curtis, L., Ait-Khaled, M., Bowlin, S. J., Hughes, S. H., Yeo, J. M., & Lapierre, D. H. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31819ff0e6 · Cited by 182
Brown, T. T., & McComsey, G. A. (2010) · Antiviral Therapy · doi:10.3851/imp1502 · Cited by 168
Labarga, P., Soriano, V., Vispo, M. E., Pinilla, J., Martín‐Carbonero, L., Castellares, C., Casado, R., Maida, I., García‐Gascó, P., & Barreiro, P. (2007) · The Journal of Infectious Diseases · doi:10.1086/520092 · Cited by 165
Clinical Pharmacokinetics and Summary of Efficacy and Tolerability of Atazanavir
Le Tiec, C., Barrail, A., Goujard, C., & Taburet, A.-M. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00003 · Cited by 159
Distribution of Health Care Expenditures for HIV-Infected Patients
Chen, R. Y., Accortt, N. A., Westfall, A. O., Mugavero, M. J., Raper, J. L., Cloud, G. A., Stone, B. K., Carter, J., Call, S., Pisu, M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/500453 · Cited by 153
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
Bierman, W. F. W., van Agtmael, M. A., Nijhuis, M., Danner, S. A., & Boucher, C. A. (2009) · AIDS · doi:10.1097/qad.0b013e32831c54e5 · Cited by 152
Malan, D. R., Krantz, E., David, N., Wirtz, V., Hammond, J., & McGrath, D. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815ace6a · Cited by 147
Podzamczer, D., Ferrer, E., Sanchez, P., Gatell, J. M., Casal, M. C., Fisac, C., Loncà, M., Sanz, J., Niubó, J., Veloso, S., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31802bf122 · Cited by 136
Grade 4 Events Are as Important as AIDS Events in the Era of HAART
Reisler, R. B., Han, C., Burman, W. J., Tedaldi, E., & Neaton, J. D. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200312010-00004 · Cited by 132
von Wyl, V. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.16.1782 · Cited by 131
Renal function with use of a tenofovir-containing initial antiretroviral regimen
Gallant, J. E., & Moore, R. D. (2009) · AIDS · doi:10.1097/qad.0b013e32832c96e9 · Cited by 129
Moyle, G. J., Baldwin, C., Langroudi, B., Mandalia, S., & Gazzard, B. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200305010-00004 · Cited by 128
Racial Differences in End-Stage Renal Disease Rates in HIV Infection versus Diabetes
Choi, A. I., Rodriguez, R. A., Bacchetti, P., Bertenthal, D., Volberding, P. A., & O’Hare, A. M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040402 · Cited by 123
Self-citationAlvarez, D., Dieterich, D. T., Bräu, N., Moorehead, L., Ball, L., & Sulkowski, M. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00749.x · Cited by 121
Friedland, G. H., Khoo, S., Jack, C., & Lalloo, U. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl399 · Cited by 120
Lau, B. M., Gange, S. J., & Moore, R. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000247229.68246.c5 · Cited by 119
Chan‐Tack, K. M., Truffa, M. M., Struble, K. A., & Birnkrant, D. B. (2007) · AIDS · doi:10.1097/qad.0b013e32813aee35 · Cited by 118
Walmsley, S. L., Avihingsanon, A., Slim, J., Ward, D. J., Ruxrungtham, K., Brunetta, J., Bredeek, U. F., Jayaweera, D. T., Guittari, C. J., Larson, P., et al. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318198a815 · Cited by 116
Parsonage, M., Wilkins, E. G., Snowden, N., Issa, B. G., & Savage, M. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00318.x · Cited by 115
Adherence to Antiretrovirals Among US Women During and After Pregnancy
Bardeguez, A. D., Lindsey, J. C., Shannon, M., TUOMALA, R. E., Cohn, S. E., Smith, E., Stek, A. M., Buschur, S., Cotter, A. M., Bettica, L., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817bbe80 · Cited by 115
van Vonderen, M. G. A., Lips, P. T. A. M., van Agtmael, M. A., Hassink, E. A. M., Brinkman, K., Geerlings, S. E., Sutinen, J., Ristola, M. A., Danner, S. A., & Reiss, P. (2009) · AIDS · doi:10.1097/qad.0b013e32832c4947 · Cited by 115
Self-citationPrevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients
Gupta, S. K., Mamlin, B. W., Johnson, C. S., Dollins, M. D., Topf, J. M., & Dubé, M. P. (2004) · Clinical Nephrology · doi:10.5414/cnp61001 · Cited by 115
Opravil, M., Ledergerber, B., Furrer, H., Hirschel, B. J., Imhof, A., Gallant, S., Wagels, T., Bernasconi, E., Meienberg, F., Rickenbach, M., et al. (2002) · AIDS · doi:10.1097/00002030-200207050-00009 · Cited by 111
Cameron, D. W., da Silva, B. A., Arribas, J. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/589622 · Cited by 111
Protease inhibitors are associated with a slowed progression of HIV-related renal diseases
Szczech, L. A., Edwards, L. J., Sanders, L. L., van der Horst, C., Bartlett, J. A., Heald, A. E., & Svetkey, L. P. (2002) · Clinical Nephrology · doi:10.5414/cnp57336 · Cited by 103
Boulanger, C., Hollender, E. S., Farrell, K., Stambaugh, J. J., Maasen, D., Ashkin, D., Symes, S. N., Espinoza, L. A., Rivero, R. O., Graham, J. J., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/606056 · Cited by 100
Lima, V. D., Harrigan, R., & Montaner, J. S. G. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31819e721b · Cited by 99
Clifford, D. B., Evans, S. R., Yang, Y., Acosta, E. P., Ribaudo, H. J., Gulick, R. M., & the Study Team (2009) · HIV Clinical Trials · doi:10.1310/hct1006-343 · Cited by 96
The UK Collaborative HIV Cohort Study Steering Committee (2007) · AIDS · doi:10.1097/qad.0b013e32827038bf · Cited by 94
Therapeutic drug monitoring of antiretrovirals for people with HIV
Kredo, T., van der Walt, J., Siegfried, N., & Cohen, K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007268.pub2 · Cited by 94
Sterling, T. R., Chaisson, R. E., Keruly, J. C., & Moore, R. D. (2003) · The Journal of Infectious Diseases · doi:10.1086/379741 · Cited by 92
Kesselring, A. M., Wit, F. W. N. M., Sabin, C. A., Lundgren, J. D., Gill, M. J., Gatell, J. M., Rauch, A., Montaner, J. S., de Wolf, F., Reiss, P., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832d3b54 · Cited by 86
Self-citationManagement of Hepatic Complications in HIV‐Infected Persons
Sulkowski, M. (2008) · The Journal of Infectious Diseases · doi:10.1086/533414 · Cited by 86
Lichtenstein, K. A., Armon, C., Buchacz, K. A., Chmiel, J. S., Moorman, A. C., Wood, K. C., Holmberg, S. D., & Brooks, J. T. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815acacc · Cited by 77
When should antiretroviral therapy for HIV be started?
Phillips, A. N., Gazzard, B., Clumeck, N., Losso, M. H., & Lundgren, J. D. (2007) · BMJ · doi:10.1136/bmj.39064.406389.94 · Cited by 74
Canducci, F., Sampaolo, M., Marinozzi, M. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328323da60 · Cited by 70
Cost-effectiveness Implications of the Timing of Antiretroviral Therapy in HIV-Infected Adults
Schackman, B. R., Freedberg, K. A., Weinstein, M. C., Sax, P. E., Losina, E., Zhang, H., & Goldie, S. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2478 · Cited by 68
Jaén, Á., Esteve, A., Miró, J. M., Tural, C., Montoliu, A., Ferrer, E., Riera, M., Segura, F., Force, L., Sued, O. G., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815ee282 · Cited by 68
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe
Hargrove, J. W., & Humphrey, J. H. (2010) · AIDS · doi:10.1097/qad.0b013e328335749d · Cited by 66
Dubé, M. P., Komarow, L., Mulligan, K. M., Grinspoon, S. K., Parker, R. A., Robbins, G. K., Roubenoff, R., & Tebas, P. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181142d26 · Cited by 66
Castro, N. D., Braun, J. M., Charreau, I., Pialoux, G., Cotte, L., Katlama, C., Raffi, F., Weiss, L., Meynard, J., Yazdanpanah, Y., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605674 · Cited by 60
Recent developments in HIV and the kidney
Post, F. A., & Holt, S. G. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328320ffec · Cited by 58
Rey, D., Hoen, B., Chavanet, P., Schmitt, M., Hoizey, G., Meyer, P., Peytavin, G., Spire, B., Allavena, C., Diemer, M., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn471 · Cited by 58
Anis, A. H., Nosyk, B., Sun, H., Guh, D. P., Bansback, N. J., Li, X., Barnett, P. G., Joyce, V. R., Swanson, K. M., Kyriakides, T. C., et al. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181a4f00d · Cited by 55
Kaplan, J. E., Hanson, D. L., Cohn, D. L., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/377606 · Cited by 51
Ward, D. J., & Curtin, J. (2006) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.20.542 · Cited by 50
von Wyl, V., Yerly, S., Böni, J., Bürgisser, P., Klimkait, T., Battegay, M., Bernasconi, E., Cavassini, M. L., Furrer, H., Hirschel, B. J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/528863 · Cited by 48
Self-citationMoyle, G. J., Higgs, C. J., Teague, A., Mandalia, S., Nelson, M. R., Johnson, M. A., Fisher, M., & Gazzard, B. (2006) · Antiviral Therapy · doi:10.1177/135965350601100106 · Cited by 43
Jenny-Avital, E. R., & Joseph, K. (2009) · Clinical Infectious Diseases · doi:10.1086/598336 · Cited by 43
Luber, A., Brower, R., Kim, D., Silverman, R., Peloquin, C. A., & Frank, I. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00496.x · Cited by 34
von Hentig, N., Koenigs, C., Elanjikal, S., et al. (2006) · PubMed · Cited by 29
Raltegravir-Based HAART Regimen in a Patient with Large B-Cell Lymphoma
Fulco, P. P., Hynicka, L. M., & Rackley, D. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m370 · Cited by 21
Wood, E., Hogg, R. S., Yip, B., Moore, D. M., Harrigan, P. R., & Montaner, J. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00430.x · Cited by 19
Design Issues in Initial HIV-Treatment Trials: Focus on Actg A5095
Ribaudo, H. J., Kuritzkes, D. R., Schackman, B. R., Acosta, E. P., Shikuma, C. M., & Gulick, R. M. (2006) · Antiviral Therapy · doi:10.1177/135965350601100605 · Cited by 15
Carosi, G., Lazzarin, A., Stellbrink, H., Moyle, G. J., Rugină, S., Staszewski, S., Givens, N., Ross, L., Granier, C., Ait‐Khaled, M., et al. (2009) · HIV Clinical Trials · doi:10.1310/hct1006-356 · Cited by 15
Bożek, K., Thielen, A., Sierra, S., Kaiser, R., & Lengauer, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007387 · Cited by 15
Risk of myocardial infarction and nucleoside analogues
Stein, J. H., & Currier, J. S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60491-2 · Cited by 13
Landman, R., Capitant, C., Descamps, D., Chazallon, C., Peytavin, G., Katlama, C., Pialoux, G., Bentata, M., Brun‐Vézinet, F., Aboulker, J.-P., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp146 · Cited by 13
Young, J., Bucher, H. C., Günthard, H. F., Rickenbach, M., Fux, C. A., Hirschel, B. J., Cavassini, M. L., Vernazza, P., Bernasconi, E., Battegay, M., et al. (2008) · Antiviral Therapy · doi:10.3851/imp1291 · Cited by 12
Self-citationNeaton, J. D., & Grund, B. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3282f3808b · Cited by 11
Hill, A. M., Miralles, D., Vangeneugden, T., & Lefebvre, E. A. (2007) · AIDS · doi:10.1097/qad.0b013e3282703593 · Cited by 10
Walmsley, S. L., Cotte, L., Rusconi, S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3282ef6db7 · Cited by 10
Lodwick, R. K., Porter, K. R., Sabin, C. A., Ledergerber, B., Cozzi‐Lepri, A., Khaykin, P., Mocroft, A., Jacobson, L. A., Wit, S. D., & Phillips, A. N. (2008) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 8
Quantifying the Importance of Interleukin-6 for Coronary Heart Disease
Neal, B. C. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050084 · Cited by 6
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506816 · Cited by 2,798
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893
Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., Gill, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081355 · Cited by 1,417
Metadata
- Authors
- Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., Richman, D. D., Rizzardini, G., Thomas, D. L., Jacobsen, D. M., & Volberding, P. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-07-25
- Volume
- 308
- Issue
- 4
- Pages
- 387-25
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2148750104
- Cited by
- 2,469
- References
- 165
- FWCI
- 232.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.